Related Experiment Videos

Potential bacterial contamination in fluorescein-anesthetic solutions

L R Duffner1, S C Pflugfelder, S Mandelbaum

  • 1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida.

Insights

Fluress demonstrated superior sterility compared to other fluorescein-anesthetic solutions. Fluress quickly regained sterility after contamination, unlike other products tested.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Pharmaceutical Science

Background:

  • Fluorescein anesthetic solutions are used in ophthalmic procedures.
  • Maintaining sterility of ophthalmic solutions and applicators is critical to prevent infections.
  • Bacterial contamination of multi-use ophthalmic preparations poses a significant risk.

Purpose of the Study:

  • To evaluate the in-vitro ability of a fluorescein-anesthetic solution (Fluress) and its applicator to regain sterility after bacterial contamination.
  • To compare the antimicrobial properties of Fluress with three other commercially available fluorescein-anesthetic solutions and their respective dropper tips.

Main Methods:

  • Four commercial fluorescein-anesthetic solutions, including Fluress, were tested.
  • Solutions and their dropper tips were deliberately contaminated with Pseudomonas species or Staphylococcus species.
  • Cultures were taken at various time points (1 minute, 5 minutes, 1 hour) post-contamination to assess bacterial regrowth.

Main Results:

  • Fluress demonstrated rapid regaining of sterility, with no organisms cultured 1 minute after solution inoculation and 5 minutes after dropper tip inoculation.
  • In contrast, the other three fluorescein-anesthetic preparations showed persistent bacterial presence for at least one hour post-contamination.
  • The differences in the ability to regain sterility between Fluress and the other preparations were statistically significant.

Conclusions:

  • Fluress exhibits superior antimicrobial properties compared to other tested fluorescein-anesthetic solutions.
  • The formulation of Fluress effectively inhibits bacterial growth, contributing to applicator and solution sterility.
  • These findings suggest Fluress may offer a reduced risk of microbial contamination in ophthalmic practice.

Related Concept Videos